Workshop agenda

AGENDA
Partial-Body Radiation Diagnostic Biomarkers and Medical Management of Radiation Injury Workshop (PB-Rad-Injury 2008 Workshop)
May 5–6, 2008
Sponsored by: Armed Forces Radiobiology Research Institute Uniformed Services University of the Health Sciences Bethesda, Maryland USA

Venue: AFRRI (location)
Monday, May 5
0730	Registration and continental breakfast
0830	Welcome and administrative remarks
Session I. Radiation dose assessment models for partial-body exposures
0900	A review of partial-body radiation accidents R.E. Goans, PhD, MJW Corp., Amherst NY; Radiation Emergency Assistance Center/Training Site, Oak Ridge, Tennessee, USA
0930	In vitro and animal models of partial-body dose exposure: Use of cytogenetic and molecular biomarkers for assessment of inhomogeneous dose exposures and radiation injury W.F. Blakely, PhD, Armed Forces Radiobiology Research Institute, Bethesda, Maryland, USA
1000	Break (posters)
1020	Statistical models for partial-body dose assessment: Gaps and approaches A. Wojcik, PhD, Stockholm University, Sweden
Session II. Partial-body exposure of cell renewal systems and survivability: Skin
1050	A new therapeutic approach of radiation burns by mesenchymal stem cell transplantation J.M. Bertho, PhD, Institut de Radioprotection et de sûreté Nucléaire, Fontenay aux roses cedex, France
1120	Role of damage to the cutaneous system in radiation-induced multi-organ failure V. Meineke, MD, Bundeswehr Institute of Radiobiology, Munich, Germany
1150	Lunch
Session III. Bone marrow and blood
1330	Cytogenetic assays for partial-body radiation accidents D.C. Lloyd, PhD, UK Health Protection Agency (HPA), Centre for Radiation, Chemical and Environmental Hazards, Chilton, United Kingdom
1400	Automated sample preparation and interlaboratory cooperative network for conducting the dicentric assay P.G.S. Prasanna, PhD, Armed Forces Radiobiology Research Institute, Bethesda, Maryland, USA
1430	Molecular biomarkers of bone marrow injury J.P. Chute, MD, Duke University Medical Center, Durham, North Carolina, USA
1500	Break (posters)
Session IV. Gut
1520	Citrulline: a serological parameter for monitoring epithelial small bowel cancer treatment-induced injury L.C.H.W. Lutgens, MD, PhD, Maastricht Radiotherapy and Oncology Clinic, Maastricht, the Netherlands
1550	Novel sphingolipid biomarkers of gut injury induced by radiation J. Saba, MD, PhD, Children's Hospital Oakland Research Center, Oakland, California, USA
Session V. Organ injury (lung, kidney, liver, thyroid)
1620	Biomarkers for renal radiation injury E.P. Cohen, MD, Medical College of Wisconsin, Milwaukee, WI, USA
1650	Adjourn
1800	Working workshop dinner
Tuesday, May 6
0730	Registration and continental breakfast
0800	Continuation of Session V: Biodosimetry in skin and mitigation in lung following radiation exposure R.P. Hill, PhD, Ontario Cancer Center/Princess Margaret Hospital, Toronto, Canada
Session VI. Novel approaches
0830	Genetic molecular markers for radiation exposure: Applications of the gene expression bioassay M.B. Grace, PhD, Armed Forces Radiobiology Research Institute, Bethesda, Maryland, USA
0900	Improvement of radiation dose assessment using multiple-protein expression and hematological profiles N.I. Ossetrova, PhD, Armed Forces Radiobiology Research Institute, Bethesda, Maryland, USA
0930	Use of optically stimulated luminescence (OSL) in radiation dosimetry E.G. Yukihara, PhD, Physics Department, Oklahoma State University, Stillwater, Oklahoma, USA
1000	Break (posters)
1020	Electron paramagnetic resonance biodosimetry in teeth and fingernails A. Romanyukha, PhD, Naval Dosimetry Center, Bethesda, Maryland, USA
Session VII. Current approaches for treatment of partial-body exposures
1050	Medical treatment of radiological casualties R.E. Goans, PhD, MJW Corp., Amherst NY; Radiation Emergency Assistance Center/Training Site, Oak Ridge, TN, USA
1120	Contingency planning for triage, supportive care, and transplantation D.J. Weisdorf, PhD, University of Minnesota, Minneapolis, Minnesota, USA
1150	Lunch
1310	Roundtable discussion—Partial-body dose assessment: Implications for treatment; conference summary
1530	Adjourn

Address all correspondence to:
Program Committee, e-mail: PB-Rad-Injury-2008@afrri.usuhs.mil; fax: 301-295-1863
Back to top

AFRRI HOME \| WORKSHOP HOME \| CONTACT \| SITE MAP